2؉ and nitric oxide levels are vital for a variety of cellular processes; however, the interaction between these two crucial messengers is not fully understood. Here, we demonstrate that expression of inducible nitric-oxide synthase in hepatocytes, in response to inflammatory mediators, dramatically attenuates Ca 2؉ signaling by the inositol 1,4,5-trisphosphateforming hormone, vasopressin. The inhibitory effects of induction were reversed by nitric oxide inhibitors and mimicked by prolonged cyclic GMP elevation. Induction was without effect on Ca 2؉ signals in response to AlF 4 ؊ or inositol 1,4,5-trisphosphate, indicating that phospholipase C activation and release of Ca 2؉ from inositol 1,4,5-trisphosphate-sensitive Ca 2؉ stores were not targets for nitric oxide inhibition. Vasopressin receptor levels, however, were dramatically reduced in induced cultures. Our data provide a possible mechanism for hepatocyte dysfunction during chronic inflammation.
Increases in both Ca
2؉ and nitric oxide levels are vital for a variety of cellular processes; however, the interaction between these two crucial messengers is not fully understood. Here, we demonstrate that expression of inducible nitric-oxide synthase in hepatocytes, in response to inflammatory mediators, dramatically attenuates Ca 2؉ signaling by the inositol 1,4,5-trisphosphateforming hormone, vasopressin. The inhibitory effects of induction were reversed by nitric oxide inhibitors and mimicked by prolonged cyclic GMP elevation. Induction was without effect on Ca 2؉ signals in response to AlF 4 ؊ or inositol 1,4,5-trisphosphate, indicating that phospholipase C activation and release of Ca 2؉ from inositol 1,4,5-trisphosphate-sensitive Ca 2؉ stores were not targets for nitric oxide inhibition. Vasopressin receptor levels, however, were dramatically reduced in induced cultures. Our data provide a possible mechanism for hepatocyte dysfunction during chronic inflammation.
Ca
2ϩ plays a pivotal role in the regulation of numerous cellular processes (1) . That increases in the cytosolic [Ca 2ϩ ] can mediate opposing cellular fates highlights the necessity and control of this ubiquitous signaling ion in cell function (1) . Such exquisite specificity is likely encoded in the remarkable spatial and temporal complexity of the Ca 2ϩ signal (2, 3) . In nonexcitable cells, Ca 2ϩ increases derive initially from mobilization of intracellular Ca 2ϩ stores (4) and are sustained by influx of Ca 2ϩ across the plasma membrane (5) . Extracellular stimuli acting on G protein-coupled receptors or receptor-tyrosine kinases converge at the level phospholipase C (PLC) 1 to mediate increases in the levels of the intracellular messenger, inositol 1,4,5-trisphosphate (IP 3 ) (4) . IP 3 in turn mediates increases in cytosolic [Ca 2ϩ ] via activation of IP 3 receptors located on the membranes of intracellular Ca 2ϩ stores (6, 7) . The concerted activity of receptors for IP 3 , ryanodine (8) , a related family of intracellular Ca 2ϩ release channels gated by cyclic ADP-ribose (9, 10) , and possibly unidentified Ca 2ϩ channels sensitive to nicotinic acid adenine dinucleotide phosphate (11) , results in generation of complex Ca 2ϩ signals (2, 12) . In hepatocytes, agonist-mediated Ca 2ϩ increases originate from a specific locus (13) , and propagate regeneratively through and between cells as intraand intercellular Ca 2ϩ waves, respectively (2) . Such coordination, which can now be visualized in the whole organ (14 -16) , is likely to integrate liver functions such as bile secretion.
Nitric oxide (NO ⅐ ) is a gaseous, short-lived messenger, which, like Ca 2ϩ , is intimately involved in cellular functions in both health and disease (17) (18) (19) . NO ⅐ is produced from the amino acid L-arginine by the NO ⅐ synthase family of enzymes (20, 21) . The constitutive forms of NO ⅐ synthase (cNOS) are expressed in certain cells, such as neurons (type I) and endothelial cells (type III), throughout their lifetime and are activated by increases in cytosolic Ca 2ϩ (20, 22) . The inducible (type II) form of nitric-oxide synthase (iNOS), is usually only expressed upon immune stimulation in cells such as macrophages, in most cases is Ca 2ϩ -insensitive, and is constitutively active (22) . Most, but not all, effects of NO ⅐ are transduced through activation of guanylate cyclase and subsequent increases in cyclic GMP concentration (23) .
Although much is known about Ca 2ϩ and NO ⅐ signaling pathways in isolation, relatively few studies have addressed the possible interactions of these messengers. Clearly stimuli that increase Ca 2ϩ in cells that express cNOS will stimulate NO ⅐ production. It is well established that NO ⅐ derived from stimulated endothelial cells can inhibit Ca 2ϩ signaling in adjacent smooth muscle effecting vasodilation (24) , albeit by a poorly defined mechanism. In contrast, we have previously demonstrated that IP 3 -dependent Ca 2ϩ signals in hepatocytes are potentiated by NO ⅐ derived either from chemical donors or bradykininstimulated endothelial cells in vitro and in vivo (25, 26) . Hepatocytes do not express cNOS but can express iNOS upon appropriate stimulation (27) . In the present study we have examined the effect of iNOS expression on agonist-mediated Ca 2ϩ signals in rat hepatocytes. In contrast to the potentiating effects of acute NO ⅐ production (25, 26) , we demonstrate that iNOS expression dramatically attenuates agonist-mediated Ca 2ϩ signals. Our data highlight the importance of controlled NO ⅐ production in liver Ca 2ϩ signaling and provide a plausible mechanism for liver dysfunction during chronic inflammation. tail, Collaborative Biomedical Products; 10 g/cm 2 ) and maintained in a humidified atmosphere of 5% CO 2 and 95% air at 37°C in Williams medium E supplemented with fetal calf serum (10% v/v), penicillin, (10 units/ml), streptomycin (10 g/ml), gentamycin sulfate (50 g/ml), glutamine (2 mM), and insulin (140 nM). After 3 h the insulin concentration in the medium was reduced to 14 nM and cells cultured for an additional 16 -20 h either in the absence or presence of an inducer mixture consisting of lipopolysaccharide (LPS; Escherichia coli 026:B6, Sigma; 10 g/ml), tumor necrosis factor-␣ (TNF-␣; murine recombinant, Invitrogen; 500 units/ml) interleukin-1␤ (IL-1␤; murine recombinant, Invitrogen; 15 units/ml), and interferon-␥ (IFN-␥; rat recombinant, Invitrogen; 100 units/ml). PPM-18 (50 M) or carboxy-PTIO (500 M, Calbiochem) were added together with the inducer mixture as indicated (Table I) . In some experiments, 8-bromo-cyclic GMP or 8-bromo-cyclic AMP (500 M) was included in the media in place of the inducer mixture. All agents were removed for at least 1 h prior to experimentation.
Immunoblotting-Cell lysates were analyzed by SDS-PAGE, transferred to nitrocellulose membranes, and antibody binding visualized by enhanced chemiluminescence using a secondary antibody conjugated to horseradish peroxidase (Amersham Biosciences) according to standard procedures (30) . Primary antibodies used were raised to iNOS (monoclonal, residues 961-1144 of the murine macrophage isoform; Transduction Laboratories), G␣ q /␣ 11 (polyclonal, common C-terminal decapeptide) (31), PLC-␤3 (polyclonal, rat C-terminal, Santa Cruz Biotechnology Inc.), and the V1a receptor (polyclonal, N-terminal, Research Diagnostics Inc.).
iNOS Immunocytochemistry-Cells were washed twice in phosphatebuffered saline (PBS) at 4°C and fixed in methanol (100%) at Ϫ20°C for 10 min. Following three washes in PBS at 25°C, cells were permeabilized with digitonin (25 g/ml, 10 min). Cells were washed again (three times) in PBS and then incubated in a blocking buffer consisting of PBS supplemented with fetal calf serum (5% v/v) and bovine serum albumin (1% w/v) for 1 h at 25°C to reduce nonspecific binding. Incubation of the primary (1/50 dilution) and secondary (1/100 dilution) antibodies (same as for immunoblotting) was performed sequentially in blocking buffer at 37°C for 1 h. Unbound antibody after each incubation was removed by washing the cells three times (5 min) in a buffer consisting of Tris-HCl (100 mM), NaCl (150 mM), and Tween 20 (0.05% v/v). Antibody binding was visualized using tyramide signal amplification. Images were captured with a Zeiss LSM 410 confocal microscope equipped with an argon laser using a standard fluorescein filter set.
Single-cell Digital Imaging Microscopy-Cytosolic calcium concentration was measured using the fluorescent Ca 2ϩ indicator, fura-2. Cells were loaded with 5 M fura-2-AM and 0.02% (w/v) Pluronic F-127 for 20 min in a buffer composed of (in mM) 121 NaCl, 4.7 KCl, 2 CaCl 2 , 1.2 MgSO 4, 1.2 KH 2 PO 4 , 5 NaHCO 3 , 10 glucose, 25 HEPES (pH 7.4 at 37°C), 0.1 bromosulfophthalein, and 0.25% (w/v) fatty acid-free bovine serum albumin. Cells were then mounted onto the stage of an inverted epifluorescence microscope and Ca 2ϩ concentration monitored by measuring the fluorescence ratio of the dye (excitation, 340 and 380 nm; emission, 420 -600 nm) using a cooled charged-coupled device. Data were collected every 3 s and corrected for autofluorescence as described (32, 33) .
For luminal calcium concentration measurements, cells were loaded with the low affinity Ca 2ϩ indicator fura-2-FF (Molecular Probes) by incubation with 6 M fura-2-FF-AM and 0.02% (w/v) Pluronic F-127 for 30 min. Cells were washed twice into an intracellular-like medium composed of (in mM) 130 KCl, 10 NaCl, 1 KH 2 PO 4 , 0.5 1,2-bis(o-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid, 0.15 CaCl 2 , 20 Tris (pH 7.2 at 37°C) supplemented with protease inhibitors (1 g/ml leupeptin, antipain, pepstatin), an ATP-regenerating system (0.5 mM creatine phosphate and 5 units/ml creatine phosphokinase), and 1 M ruthenium red. Cells were permeabilized with digitonin (10 g/ml) and released dye (monitored by loss of cytosolic fluorescence) removed by two more washes in complete intracellular-like medium. Ca 2ϩ uptake into intracellular stores was initiated by the addition of Mg-ATP (2 mM) and changes in luminal [Ca 2ϩ ] followed by monitoring the fluorescence ratio of the compartmentalized dye (excitation, 340 and 380 nm; emission, 420 -600 nm) at 3-s intervals as above.
Radioligand Binding-Control and induced cultures were washed twice with a medium composed of (in mM) 116 NaCl, 5.6 KCl, 1.2 NaH 2 PO 4 , 5 NaHCO 3 , and 20 HEPES (pH 7.4) and suspended (2 ϫ 10 7 cells/ml) in ice-cold homogenization medium composed of (in mM) 1 EDTA, 0.1 phenylmethylsulfonyl fluoride, and 10 Tris-HCl (pH 7.4). Cell suspensions were incubated for 30 min and disrupted at 4°C by 15 strokes in a Potter homogenizer (Teflon/glass, tight piston). Following centrifugation (100 ϫ g, 10 min, 4°C), supernatant fractions were collected and further centrifuged at 21,000 ϫ g (15 min at 4°C). Pellets were resuspended in homogenization medium at a protein concentration of 3-5 mg/ml and stored at Ϫ80°C prior to use. Binding of increasing concentrations of [ 125 I]OH-LVA (specific activity, 2000 Ci/mmol) to membranes was performed in quadruplicate from two independent cultures at 37°C as described previously (34) . Bound and free ligand were separated by filtration through Whatman GF/C filters (Clifton, NJ). Nonspecific binding was determined in the presence of 1 M unlabeled vasopressin.
Semiquantitative RT-PCR-Total RNA was extracted from control or induced cultures using RNeasy total RNA isolation kit (Qiagen) and samples (5 g) reverse transcribed into single-stranded cDNA using oligo(dT) 15 primers and 1st Strand cDNA synthesis kit for RT-PCR (Roche Molecular Biochemicals). Aliquots of the RT-PCR mixture were amplified using the Expand Long Template PCR system (Roche) with primers based on the reported sequence of the rat V1a receptor (forward, 5Ј-ATG AGT TTC CCG CGA GGC T-3Ј; reverse, 5Ј-TTG GAC GCA GTC TTG CAG GA-3Ј) (35) and ␤-actin (forward, 5Ј-ATC TGG CAC CAC ACC TTC TAC AAT GAG CTG CG-3Ј; reverse, 5Ј-CGT CAT ACT CCT GCT TGC TGA TCC ACA TCT GC-3Ј) as an internal control. PCR was performed in a PerkinElmer Life Sciences Thermocycler (32 cycles consisting of 30 s at 96°C, 45 s at 59°C, followed by 3 min at 72°C) and samples analyzed by electrophoresis in ethidium bromideimpregnated 2% agarose gels.
Other Methods-Flash photolysis of microinjected caged IP 3 and monitoring of cytosolic [Ca 2ϩ ] using fluo-3 were performed exactly as described (29) . Protein concentration was determined using Biuret reagent (Sigma). All data are expressed as means Ϯ S.E. of the mean.
RESULTS
Expression of iNOS-Hepatocytes cultured in the presence of LPS, TNF-␣, IL-1␤, and IFN-␥ (see "Experimental Procedures") expressed a protein with a molecular mass of 142 Ϯ 5 kDa (n ϭ 3) that was recognized by an antibody raised to iNOS from murine macrophages (Fig. 1A) . This protein was expressed throughout the cytoplasm and found to be concentrated in certain regions, particularly in the cell periphery (Fig. 1B) . Only a small proportion of cells (Ͻ5%) from control cultures stained positively for iNOS (Fig. 1C) . The observed iNOS distribution was specific because no staining was observed in the absence of primary antibody (Fig. 1D) .
iNOS (Fig. 2B) ; no response to submaximal VP concentrations were observed in a majority of cells (Table I) . Reduced sensitivity was also observed at supramaximal VP concentrations (Table I) . Analysis of complete concentration-effect relationships (Fig. 3) indicated that the concentration of VP required to stimulate Ca 2ϩ increases in 50% of the cells (EC 50 ) was 1 and 4.8 nM in control and induced cells, respectively, and that the percentage of cells responsive to a maximal concentration of VP was reduced from 88% to 41% upon induction. Similar inhibitory effects of induction were observed when cells were stimulated with the ␣-adrenergic agonist, phenylephrine (data not shown). Increases in cytosolic [Ca 2ϩ ] in response to cyclopiazonic acid, a reversible Ca 2ϩ -ATPase inhibitor, however, were similar in control (peak cytosolic [Ca 2ϩ ] ϭ 757 Ϯ 28 nM, n ϭ 78 cells) and induced (peak cytosolic [Ca 2ϩ ] ϭ 709 Ϯ 27 nM, n ϭ 89 cells) cultures. Both carboxy-PTIO (500 M), an NO ⅐ scavenger (36) , and PPM-18 (50 M), an inhibitor of iNOS expression (37), were able to reverse the inhibitory effects of induction (Table I) . We confirmed by immunocytochemistry that PPM-18 blocked iNOS expression under our experimental conditions (data not shown). These data indicate that attenuation of VP-dependent Ca 2ϩ signaling in induced cultures was caused by NO ⅐ derived from iNOS expression.
Cyclic GMP Attenuates Vasopressin-dependent Ca 2ϩ Signaling-Because many of the effects of NO ⅐ are mediated by increases in cyclic GMP (38), we examined the effects of elevating cyclic GMP levels on VP sensitivity. Previously, we have shown that brief incubations (10 min) with cell-permeable cyclic GMP analogues potentiated IP 3 -dependent Ca 2ϩ signaling (25, 40) . In contrast, cells cultured in the prolonged (16 -20 h) presence of 8-bromo-cyclic GMP (500 M), were significantly less responsive to VP than untreated cells (Fig. 4A, Table I ). Cells treated with 8-bromo-cAMP, however, were marginally more responsive to VP than control cells (Fig. 4B, Table I ) an effect probably resulting from phosphorylation and sensitization of hepatic IP 3 receptors by cyclic AMP-dependent protein kinase (41) (42) (43) (Fig. 5) . Permeabilized hepatocytes readily accumulated Ca 2ϩ into intracellular stores in response to ATP. Once steady-state loading had been achieved, a submaximal IP 3 concentration resulted in partial release of the accumulated Ca 2ϩ . A maximal IP 3 concentration effected a more rapid and robust response. The remaining IP 3 -insensitive store could be released with the divalent ionophore, ionomycin. Although sensitivity to VP in intact cells was severely compromised in induced cultures ( Fig. 2 and Table I), the IP 3 sensitivity of these cells when permeabilized appeared normal (Fig.  4B) . Thus, a submaximal concentration of IP 3 for control and induced cultures, respectively). Prolonged 8-bromo-cyclic GMP treatment was also without effect on IP 3 sensitivity in permeabilized cells (data not shown).
One concern was that any possible effects of NO ⅐ on the IP 3 receptor may be reversed upon permeabilization of the cell because iNOS is predominantly a cytosolic enzyme. We therefore assessed IP 3 sensitivity in intact cells by using caged IP 3 . Control cells injected with caged IP 3 responded to submaximal VP concentrations in the typical oscillatory fashion (Fig. 6A) . Following washout of the agonist, photolytic liberation of IP 3 resulted in a transient increase in cytosolic [Ca 2ϩ ] (Fig. 6A) . In induced cultures, VP was without effect on the cytosolic [Ca 2ϩ ]; however, the response to uncaging of IP 3 (peak increase ϭ 14 Ϯ 4%, area under curve ϭ 2694 Ϯ 992 arbitrary units, n ϭ 9; Fig.  6B ) was indistinguishable from control cells (peak increase ϭ 17 Ϯ 3%, area under curve ϭ 3021 Ϯ 711 arbitrary units, n ϭ 4, Fig. 6A ). The response was specific to the presence of IP 3 , because no response was observed upon UV illumination in cells not injected with the caged precursor (n ϭ 9; Fig. 6B , lower trace). These data, together with results from permeabilized cells (Fig. 5) , strongly suggest that the target for NO ⅐ is upstream of the IP 3 receptor.
iNOS Expression Does Not Affect G Protein or PLC Activity-VP acts on the V1a receptor expressed in hepatocytes to stimulate PLC through G␣ q /G␣ 11 activation (44). AlF 4 Ϫ , however, can induce Ca 2ϩ oscillations in hepatocytes independently of cell surface receptor occupancy through direct activation of G proteins (13, 29, 45) . We therefore compared the effects of AlF 4 Ϫ in control and induced cultures. Cells from both cultures responded to AlF 4 Ϫ with oscillations in cytosolic [Ca 2ϩ ] reminiscent of those evoked by IP 3 -forming hormones ( Fig. 7 and Table I ). As expected, only the control cultures responded to VP (Fig. 7A) . From Western blot analysis, protein levels of G␣ q /G␣ 11 and PLC-␤3 in induced cultures were 110 Ϯ 9% (n ϭ 12) and 106 Ϯ 3% (n ϭ 18), respectively, of that in control cultures (Fig. 8) . These data indicate that G protein and PLC are unaffected by iNOS expression.
iNOS iments showed that amplification of an 1100-base pair product, corresponding to amino acids 1-367 of the V1a receptor (35) , was markedly lower in induced cultures (Fig. 9B) . From densitometric analysis, the VP receptor/␤-actin mRNA ratio decreased from 0.65 Ϯ 0.1 in control cultures to 0.25 Ϯ 0.08 in induced cultures (n ϭ 4 preparations). Taken together, these data suggest that attenuation of VP-induced Ca 2ϩ signaling in the induced cultures is likely caused by down-regulation of VP receptors. 2 
DISCUSSION
In the present study we have examined the effects of iNOS expression on hepatocyte Ca 2ϩ signaling. The major finding of our study is that cultures expressing iNOS are dramatically less sensitive to VP, an IP 3 -forming hormone, than control cultures. Increases in cytosolic [Ca 2ϩ ] in response to direct activation of G proteins or IP 3 receptors, however, were not affected by iNOS expression, indicating that the inhibitory effects of NO ⅐ are mediated at the plasma membrane receptor level. Consistent with this, we have demonstrated that cell surface vasopressin receptor levels are reduced in iNOSexpressing cultures.
Consistent with previous reports (27) , hepatocytes cultured in the presence of LPS, TNF-␣, IL-1␤, and IFN-␥ expressed iNOS. (Fig. 1) . Our estimation of the molecular mass of rat hepatocyte iNOS (142 kDa) is in agreement with that calculated from the primary sequence from human hepatocytes (131 kDa) (27) . That the observed inhibition of VP-mediated Ca 2ϩ signals was caused by NO ⅐ was confirmed by the demonstration that two mechanistically distinct inhibitors of NO ⅐ signaling could reverse the effects of induction (Table I) . These data argue against any direct effects of the inducers on Ca 2ϩ signals in hepatocytes. Indeed, inhibition of Ca 2ϩ signaling was observed at least 1 h following washout of the inducers.
Remarkably, the present data are in stark contrast to our previous studies demonstrating a potentiating effect of NO ⅐ donors (25, 26) and endogenous NO ⅐ derived from bradykininstimulated endothelial cells (26) 
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bradykinin receptors, whereas iNOS, once expressed, is constitutively active. Thus, the differences in the effects of NO ⅐ on hepatocyte Ca 2ϩ signaling may be the result of differences in the levels of NO ⅐ produced; low NO ⅐ concentrations may stimulate, whereas sustained higher concentrations likely inhibit, IP 3 -dependent Ca 2ϩ signaling. Alternatively, the time of NO ⅐ exposure may determine the effects on Ca 2ϩ signaling. Potentiation of Ca 2ϩ signaling was observed following acute NO ⅐ treatment (within 5 min), whereas induced cultures were exposed to NO ⅐ for several hours. Indeed, the same concentration of cyclic GMP (500 M) potentiated agonist-dependent Ca 2ϩ signals for up to 5 h (data not shown) but was inhibitory following longer incubation periods (Fig. 4) . Thus, it appears that the duration and mode of delivery of NO ⅐ are crucial in setting agonist sensitivity.
NO ⅐ has been reported to both inhibit and potentiate Ca 2ϩ signaling in a variety of cell types (46, 47) . However, most studies have examined the effects of NO ⅐ donors and almost nothing is known concerning the effects of endogenously produced NO ⅐ . In smooth muscle cells, NO ⅐ derived from the adjacent endothelium inhibits Ca 2ϩ signals and thus contractility (24) . However, the molecular mechanism mediating NO ⅐ inhibition is somewhat unclear. One possible NO ⅐ target is the IP 3 receptor. Indeed, cyclic GMP-dependent protein kinase phosphorylates IP 3 receptors in several cell types (6) 49 ). In the present study, however, iNOS induction (or prolonged cyclic GMP elevation) was without effect on IP 3 sensitivity in both permeabilized (Fig. 5 ) and intact cells (Fig. 6) . Thus, in iNOS-expressing hepatocytes, the locus of inhibition by NO ⅐ is upstream of the IP 3 receptor.
NO ⅐ /cyclic GMP donors have been reported to inhibit phosphoinositide turnover in several cell types including smooth muscle (50) , platelets (51), CHO cells overexpressing cyclic GMP-dependent protein kinase (52, 53) , and neurons (54). However, iNOS-expressing hepatocytes responded vigorously to AlF 4 Ϫ (Fig. 7 , Table I ), suggesting normal PLC activity and further confirming that iNOS does not affect IP 3 receptors. These data also indicate that coupling of G proteins to PLC is uncompromised, another proposed target for NO ⅐ action (50) . Indeed, levels of both G␣ q /␣ 11 and PLC-␤3 were similar in control and induced cultures (Fig. 8) . Thus, the plasma membrane receptor for VP is most likely the target for this remarkably specific NO ⅐ inhibition. In support, we have demonstrated a dramatic decrease in the VP receptor mRNA levels in induced relative to control cultures (Fig. 9B) . Furthermore, our radioligand binding data (Fig. 9A) show that reduced VP receptor mRNA in induced cultures is associated with reduced numbers of functional, cell surface VP receptors. To our knowledge, this is the first report demonstrating down-regulation of a G protein-coupled receptor by NO ⅐ . Additional inhibitory effects of NO ⅐ on coupling of receptors to their respective G proteins cannot be ruled out at this stage. Of note, that the EC 50 for VP-induced Ca 2ϩ mobilization is increased in induced cells relative to control cells (Fig. 3 ) would be consistent with NO ⅐ -mediated inhibition of receptor-G protein coupling. Indeed, in aortic smooth muscle cells, cyclic GMP has been shown to block VP-stimulated GTPase activity (50) .
Clearly then, our data suggest that iNOS induction in hepatocytes is associated with defective Ca 2ϩ signaling, a finding that has important implications for liver function during pathogenesis. Sepsis is a systemic inflammatory condition that ultimately results in multiple organ failure and death. The molecular basis for organ dysfunction during sepsis, however, is unclear. iNOS expression has been demonstrated in several cell types isolated from endotoxemic rats including hepatocytes (56) . From our data, we propose that compromised liver function during chronic inflammation may result from aberrant Ca 2ϩ signaling in hepatocytes as a result of iNOS expression. Indeed, total VP and ␣-adrenergic receptor binding sites are reduced in rats chronically treated with endotoxin (57), consistent with our data showing reduced levels of VP receptor mRNA (Fig. 9B) and [ 125 I]OH-LVA binding sites (Fig. 9A ) in iNOSexpressing cultures. Moreover, the liver is the major source of circulating glucose and alterations in glucose metabolism is a hallmark feature of sepsis. Hypoglycemia, associated with the later phases of sepsis, is likely to result from inhibition of both gluconeogenesis and glycogenolysis, both of which are activated by Ca 2ϩ in the liver. An intriguing possibility, then, is that perturbations in hepatocyte Ca 2ϩ signaling during sepsis will inhibit phosphorylase kinase, a Ca 2ϩ -dependent enzyme, thereby reducing activation of glycogen phosphorylase and subsequent mobilization of glycogen stores. Furthermore, diminished sensitivity to Ca 2ϩ mobilizing stimuli is more than likely to reduce bile acid secretion, another important Ca 2ϩ -dependent liver function, which is also impaired during sepsis and in response to endotoxin (58 -60) . Although liver damage in response to bacterial infection in iNOS knockout mice is not improved relative to control litter mates (61) , these findings may highlight redundant mechanisms in combating infection. Indeed, NO ⅐ inhibition using NOS antagonists does reduce liver damage in some models of sepsis (62-64).
In summary, we have demonstrated that endogenously produced NO ⅐ via iNOS expression in hepatocytes dramatically attenuates receptor-mediated Ca 2ϩ signaling through downregulation of cell surface VP receptor levels. Our data suggest that such perturbation in Ca 2ϩ -dependent signaling is likely to have profound consequences on hepatocyte function during inflammation.
